How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 7 people who said how it went. 1 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 1 | 14% |
| Helped | 4 | 57% |
| No change | 2 | 29% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 3 | 5 | |
| Recovery stories | 2 | 2 |
Did it last, for everyone it helped?
- None of the 5 people it helped said it wore off, whether or not they credit it for their improvement.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 3 people who said how it went. 1 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 1 | 33% |
| No change | 2 | 67% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 3 people who said how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 3 | 100% |
| No change | 0 | 0% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 2 | 2 | |
| Recovery stories | 1 | 1 |
Did it last, for everyone it helped?
- None of the 3 people it helped said it wore off, whether or not they credit it for their improvement.
Ask about this treatment
The one person who credits it with their improvement: here’s how they are now
Credit it means they say it’s one reason they got better: 1 says it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 1 | 100% |
| Relapsed | 0 | 0% |
Did it last?
- No one said its benefit wore off.
- 1 of 1 who credits it says they still need to keep doing something (not always this) to stay well.
No one with long COVID credits it with their improvement
Credit it means they say it’s one reason they got better.
No one with ME/CFS credits it with their improvement
Credit it means they say it’s one reason they got better.
Everyone · not split by condition
By how ill people were
Only the one person who credits it, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall, not the effect of this one treatment.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Mild | 1 | 0%, few people |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Mild | Somewhat better | 1 of 1 | 100% |
Everyone · not split by condition
Adverse events
None of the 8 people who wrote about taking it described an adverse event they tied to it.
People don’t always write about every problem they had, so harms are likely under-reported.
All posts · not split by condition
How often it comes up
Posts that mention Mirabegron (Myrbetriq), per 1,000 posts each month. Hover or tap a point for the count.
| Month | Posts mentioning it | All posts | Per 1,000 |
|---|---|---|---|
| Oct 2009 | 0 | 105 | 0 |
| Jan 2010 | 0 | 141 | 0 |
| Feb 2010 | 0 | 113 | 0 |
| Jun 2011 | 0 | 109 | 0 |
| Nov 2011 | 0 | 124 | 0 |
| Dec 2011 | 0 | 199 | 0 |
| Jan 2012 | 0 | 232 | 0 |
| Feb 2012 | 0 | 103 | 0 |
| Mar 2012 | 0 | 190 | 0 |
| Apr 2012 | 0 | 162 | 0 |
| May 2012 | 0 | 375 | 0 |
| Jun 2012 | 0 | 238 | 0 |
| Jul 2012 | 0 | 240 | 0 |
| Aug 2012 | 0 | 485 | 0 |
| Sep 2012 | 0 | 561 | 0 |
| Oct 2012 | 0 | 526 | 0 |
| Nov 2012 | 0 | 514 | 0 |
| Dec 2012 | 0 | 699 | 0 |
| Jan 2013 | 0 | 533 | 0 |
| Feb 2013 | 0 | 447 | 0 |
| Mar 2013 | 0 | 429 | 0 |
| Apr 2013 | 0 | 499 | 0 |
| May 2013 | 0 | 606 | 0 |
| Jun 2013 | 0 | 609 | 0 |
| Jul 2013 | 0 | 616 | 0 |
| Aug 2013 | 0 | 577 | 0 |
| Sep 2013 | 0 | 364 | 0 |
| Oct 2013 | 0 | 536 | 0 |
| Nov 2013 | 0 | 385 | 0 |
| Dec 2013 | 0 | 519 | 0 |
| Jan 2014 | 0 | 944 | 0 |
| Feb 2014 | 0 | 821 | 0 |
| Mar 2014 | 0 | 425 | 0 |
| Apr 2014 | 0 | 361 | 0 |
| May 2014 | 0 | 617 | 0 |
| Jun 2014 | 0 | 489 | 0 |
| Jul 2014 | 0 | 444 | 0 |
| Aug 2014 | 0 | 622 | 0 |
| Sep 2014 | 0 | 507 | 0 |
| Oct 2014 | 0 | 678 | 0 |
| Nov 2014 | 0 | 567 | 0 |
| Dec 2014 | 0 | 629 | 0 |
| Jan 2015 | 0 | 760 | 0 |
| Feb 2015 | 0 | 873 | 0 |
| Mar 2015 | 0 | 1,276 | 0 |
| Apr 2015 | 0 | 984 | 0 |
| May 2015 | 0 | 1,496 | 0 |
| Jun 2015 | 0 | 1,046 | 0 |
| Jul 2015 | 0 | 1,211 | 0 |
| Aug 2015 | 0 | 998 | 0 |
| Sep 2015 | 0 | 1,060 | 0 |
| Oct 2015 | 0 | 1,255 | 0 |
| Nov 2015 | 0 | 1,246 | 0 |
| Dec 2015 | 0 | 924 | 0 |
| Jan 2016 | 0 | 1,282 | 0 |
| Feb 2016 | 0 | 1,051 | 0 |
| Mar 2016 | 0 | 1,002 | 0 |
| Apr 2016 | 0 | 998 | 0 |
| May 2016 | 0 | 1,045 | 0 |
| Jun 2016 | 0 | 1,230 | 0 |
| Jul 2016 | 0 | 1,619 | 0 |
| Aug 2016 | 0 | 1,729 | 0 |
| Sep 2016 | 0 | 1,785 | 0 |
| Oct 2016 | 0 | 1,220 | 0 |
| Nov 2016 | 0 | 1,092 | 0 |
| Dec 2016 | 0 | 1,211 | 0 |
| Jan 2017 | 0 | 1,660 | 0 |
| Feb 2017 | 0 | 1,988 | 0 |
| Mar 2017 | 0 | 2,078 | 0 |
| Apr 2017 | 0 | 2,133 | 0 |
| May 2017 | 0 | 2,370 | 0 |
| Jun 2017 | 0 | 2,194 | 0 |
| Jul 2017 | 0 | 2,183 | 0 |
| Aug 2017 | 0 | 2,466 | 0 |
| Sep 2017 | 0 | 2,189 | 0 |
| Oct 2017 | 0 | 3,042 | 0 |
| Nov 2017 | 0 | 1,976 | 0 |
| Dec 2017 | 0 | 2,112 | 0 |
| Jan 2018 | 0 | 2,620 | 0 |
| Feb 2018 | 0 | 2,155 | 0 |
| Mar 2018 | 0 | 2,613 | 0 |
| Apr 2018 | 0 | 2,251 | 0 |
| May 2018 | 0 | 2,828 | 0 |
| Jun 2018 | 0 | 3,871 | 0 |
| Jul 2018 | 0 | 3,067 | 0 |
| Aug 2018 | 0 | 3,757 | 0 |
| Sep 2018 | 0 | 3,512 | 0 |
| Oct 2018 | 0 | 3,261 | 0 |
| Nov 2018 | 0 | 2,861 | 0 |
| Dec 2018 | 0 | 2,754 | 0 |
| Jan 2019 | 0 | 3,672 | 0 |
| Feb 2019 | 0 | 2,715 | 0 |
| Mar 2019 | 0 | 3,317 | 0 |
| Apr 2019 | 0 | 3,141 | 0 |
| May 2019 | 0 | 3,855 | 0 |
| Jun 2019 | 0 | 3,392 | 0 |
| Jul 2019 | 0 | 3,312 | 0 |
| Aug 2019 | 0 | 3,943 | 0 |
| Sep 2019 | 0 | 4,035 | 0 |
| Oct 2019 | 0 | 3,922 | 0 |
| Nov 2019 | 0 | 3,508 | 0 |
| Dec 2019 | 0 | 3,659 | 0 |
| Jan 2020 | 0 | 4,650 | 0 |
| Feb 2020 | 0 | 4,374 | 0 |
| Mar 2020 | 0 | 4,475 | 0 |
| Apr 2020 | 0 | 3,690 | 0 |
| May 2020 | 0 | 4,543 | 0 |
| Jun 2020 | 0 | 5,701 | 0 |
| Jul 2020 | 0 | 6,104 | 0 |
| Aug 2020 | 0 | 10,333 | 0 |
| Sep 2020 | 0 | 11,958 | 0 |
| Oct 2020 | 0 | 14,568 | 0 |
| Nov 2020 | 0 | 16,546 | 0 |
| Dec 2020 | 0 | 20,764 | 0 |
| Jan 2021 | 1 | 24,562 | 0.04 |
| Feb 2021 | 0 | 24,672 | 0 |
| Mar 2021 | 0 | 29,476 | 0 |
| Apr 2021 | 0 | 28,509 | 0 |
| May 2021 | 0 | 25,791 | 0 |
| Jun 2021 | 0 | 27,871 | 0 |
| Jul 2021 | 0 | 27,220 | 0 |
| Aug 2021 | 0 | 30,808 | 0 |
| Sep 2021 | 0 | 30,074 | 0 |
| Oct 2021 | 0 | 22,132 | 0 |
| Nov 2021 | 0 | 27,722 | 0 |
| Dec 2021 | 0 | 31,872 | 0 |
| Jan 2022 | 0 | 42,317 | 0 |
| Feb 2022 | 0 | 38,697 | 0 |
| Mar 2022 | 0 | 44,305 | 0 |
| Apr 2022 | 0 | 44,333 | 0 |
| May 2022 | 0 | 50,594 | 0 |
| Jun 2022 | 0 | 49,058 | 0 |
| Jul 2022 | 0 | 53,485 | 0 |
| Aug 2022 | 0 | 54,455 | 0 |
| Sep 2022 | 0 | 56,936 | 0 |
| Oct 2022 | 0 | 58,511 | 0 |
| Nov 2022 | 0 | 59,198 | 0 |
| Dec 2022 | 0 | 61,576 | 0 |
| Jan 2023 | 0 | 61,004 | 0 |
| Feb 2023 | 0 | 50,133 | 0 |
| Mar 2023 | 0 | 59,925 | 0 |
| Apr 2023 | 1 | 54,251 | 0.02 |
| May 2023 | 0 | 57,768 | 0 |
| Jun 2023 | 0 | 52,679 | 0 |
| Jul 2023 | 0 | 56,401 | 0 |
| Aug 2023 | 1 | 65,435 | 0.02 |
| Sep 2023 | 0 | 61,835 | 0 |
| Oct 2023 | 0 | 58,419 | 0 |
| Nov 2023 | 2 | 53,662 | 0.04 |
| Dec 2023 | 2 | 60,643 | 0.03 |
| Jan 2024 | 1 | 71,818 | 0.01 |
| Feb 2024 | 0 | 70,045 | 0 |
| Mar 2024 | 1 | 68,261 | 0.01 |
| Apr 2024 | 0 | 64,374 | 0 |
| May 2024 | 0 | 67,698 | 0 |
| Jun 2024 | 0 | 64,720 | 0 |
| Jul 2024 | 3 | 65,335 | 0.05 |
| Aug 2024 | 0 | 68,517 | 0 |
| Sep 2024 | 0 | 70,168 | 0 |
| Oct 2024 | 0 | 72,607 | 0 |
| Nov 2024 | 0 | 71,802 | 0 |
| Dec 2024 | 1 | 74,401 | 0.01 |
| Jan 2025 | 0 | 77,909 | 0 |
| Feb 2025 | 0 | 65,110 | 0 |
| Mar 2025 | 0 | 69,905 | 0 |
| Apr 2025 | 0 | 61,606 | 0 |
| May 2025 | 0 | 65,733 | 0 |
| Jun 2025 | 0 | 60,540 | 0 |
| Jul 2025 | 0 | 62,105 | 0 |
| Aug 2025 | 3 | 64,578 | 0.05 |
| Sep 2025 | 0 | 61,704 | 0 |
| Oct 2025 | 0 | 59,204 | 0 |
| Nov 2025 | 1 | 58,944 | 0.02 |
| Dec 2025 | 0 | 62,830 | 0 |
| Jan 2026 | 0 | 63,321 | 0 |
| Feb 2026 | 0 | 53,085 | 0 |
| Mar 2026 | 1 | 59,208 | 0.02 |
| Apr 2026 | 0 | 53,989 | 0 |
| May 2026 | 0 | 57,541 | 0 |
| Jun 2026 | 0 | 55,301 | 0 |
| Jul 2026 | 0 | 56,391 | 0 |
| Aug 2026 | 1 | 56,825 | 0.02 |
| Sep 2026 | 1 | 57,143 | 0.02 |
Forum and Reddit posts, 4,007,898 in all, counted per month. A mention means the post names the treatment, not that the writer took it. All trends
All 8 people who tried it
-
busybee on Phoenix Rising
busybee reported aching flu-like crashes, migraine-type headaches and neuralgia across posts from 2009 to 2016, and described recovering very slowly. Cleaning up the diet and giving up soya yogurt and dairy eased neuralgia, shoulder and neck inflammation and…
-
Long COVID largely housebound, improved with nicotine patches and mestinon, then relapsed
Glade 60608 developed long COVID after a mild 2022 infection, with POTS and later an ME/CFS-like illness that left them largely housebound. Nicotine patches, mestinon and CGRP migraine drugs (Nurtec, then Qulipta) raised their baseline enough to accept a…
-
Moderate-severe ME/CFS, now mild-moderate and working after specialist care and Rapamycin
An emergency nurse in Canada who caught COVID at work in 2022, they pushed on until moderate-severe ME/CFS. Specialist care, LDN, Mestinon and other drugs stabilised them; Rapamycin in 2025 shortened PEM and raised their energy budget from 4 to 6-7 hours a…
-
Long COVID left her barely able to walk; recovered with rest and time
Glacier 58324 caught COVID in June 2020 and had 12 good days before long-COVID symptoms began, leaving her barely able to walk down the street. About a year later she was still long hauling but significantly recovered; a second Moderna dose caused months of…
-
Long COVID bladder pain and brain fog, better after functional medicine then worse
A man developed urinary urgency and frequency after mild Covid in June 2022, later attributed to a tick-borne infection, followed by bladder pain, poor sleep, tingling and brain fog. Functional-medicine care left him about 25% better; a sacral…
-
ME/CFS sleep problems and night-time urination; earplugs and pregabalin
They used wax earplugs and noise protectors and said they could not live without the earplugs. They reported that pregabalin or gabapentin made a night-and-day difference to their sleep, and that solifenacin reduced night-time urination while paracetamol…
-
Long COVID with insomnia, reflux and interstitial cystitis, somewhat better with B1, B12
Badger 44582 developed long COVID in September 2022 after covid pneumonia that put her in hospital for a week, with insomnia, anxiety, severe reflux, interstitial cystitis and a drop in kidney function that later improved. She credits B1, B12 and vitamin D…
-
Belgiangirl on Phoenix Rising
Belgiangirl, ill with ME/CFS since age 16 and bedbound for years at her worst, said hydroxychloroquine (Plaquenil) in 2019 cut her fatigue and brain fog by 60-75%, after earlier gains from vitamin infusions and B12 injections. It also brought lung, eye and…
The first one credits Mirabegron (Myrbetriq) for their improvement; the other 7 tried it without crediting it.
All 4 people who tried it
-
Long COVID largely housebound, improved with nicotine patches and mestinon, then relapsed
Glade 60608 developed long COVID after a mild 2022 infection, with POTS and later an ME/CFS-like illness that left them largely housebound. Nicotine patches, mestinon and CGRP migraine drugs (Nurtec, then Qulipta) raised their baseline enough to accept a…
-
Long COVID left her barely able to walk; recovered with rest and time
Glacier 58324 caught COVID in June 2020 and had 12 good days before long-COVID symptoms began, leaving her barely able to walk down the street. About a year later she was still long hauling but significantly recovered; a second Moderna dose caused months of…
-
Long COVID bladder pain and brain fog, better after functional medicine then worse
A man developed urinary urgency and frequency after mild Covid in June 2022, later attributed to a tick-borne infection, followed by bladder pain, poor sleep, tingling and brain fog. Functional-medicine care left him about 25% better; a sacral…
-
Long COVID with insomnia, reflux and interstitial cystitis, somewhat better with B1, B12
Badger 44582 developed long COVID in September 2022 after covid pneumonia that put her in hospital for a week, with insomnia, anxiety, severe reflux, interstitial cystitis and a drop in kidney function that later improved. She credits B1, B12 and vitamin D…
None of them credit Mirabegron (Myrbetriq) for their improvement.
All 3 people who tried it
-
Moderate-severe ME/CFS, now mild-moderate and working after specialist care and Rapamycin
An emergency nurse in Canada who caught COVID at work in 2022, they pushed on until moderate-severe ME/CFS. Specialist care, LDN, Mestinon and other drugs stabilised them; Rapamycin in 2025 shortened PEM and raised their energy budget from 4 to 6-7 hours a…
-
ME/CFS sleep problems and night-time urination; earplugs and pregabalin
They used wax earplugs and noise protectors and said they could not live without the earplugs. They reported that pregabalin or gabapentin made a night-and-day difference to their sleep, and that solifenacin reduced night-time urination while paracetamol…
-
Belgiangirl on Phoenix Rising
Belgiangirl, ill with ME/CFS since age 16 and bedbound for years at her worst, said hydroxychloroquine (Plaquenil) in 2019 cut her fatigue and brain fog by 60-75%, after earlier gains from vitamin infusions and B12 injections. It also brought lung, eye and…
None of them credit Mirabegron (Myrbetriq) for their improvement.